FrancophonIA/ELRC3.0 huggingface dataset:
English: TAZOCIN 2g/0.25g contains 2 active ingredients; piperacillin 2g and tazobactam 0.25g both present as sodium salts.
Icelandic: TAZOCIN 2g/0,25g inniheldur 2 virk innihaldsefni; píperasillín 2g og tazóbaktam 0,25g hvort tveggja til staðar sem natríumsölt.
English: Sodium piperacillin 2.085 g sodium tazobactam 268.300 mg
Icelandic: Natríum píperasillín 2,085 g natríum tazóbaktam 268,300 mg
English: Sodium piperacillin and sodium tazobactam, equivalent to 2 g piperacillin and 250 mg tazobactam.
Icelandic: Natríum píperasillín og natríum tazóbaktam, sem jafngildir 2 g píperasillíns og 250 mg tazóbaktams.
English: Slovenia
Icelandic: Slovakía
English: 2.00 g as piperacillin sodium and tazobactam 0.25 g as tazobactam sodium.
Icelandic: 2,00 g as píperasillín natríum og tazóbaktam 0,25 g sem tazóbaktam natríum
English: Sodium piperacillin and sodium tazobactam, equivalent to 4 g piperacillin and 500 mg tazobactam
Icelandic: Natríum píperasillín og natríum tazóbaktam, sem jafngildir 4 g píperasillíns og 500 mg tazóbaktams
English: TAZOCIN 4g/0.5g contains 2 active ingredients; piperacillin 4g and tazobactam 0.5g both present as sodium salts.
Icelandic: TAZOCIN 4g/0,5g inniheldur 2 virk innihaldsefni; píperasillín 4g og tazóbaktam 0,5g hvort tveggja til staðar sem natríumsölt.
English: sodium 4.170 g
Icelandic: Píperasillín natríum 4,170 g
English: Sodium piperacillin 4.170 g sodium tazobactam 536.600 mg
Icelandic: Natríum píperasillín 4,170 g natríum tazóbaktam 536,600 mg
English: Piperacillin (in the form of piperacillin sodium) 4 g Tazobactam (in the form of tazobactam sodium) 0.50 g
Icelandic: Píperasillín (í formi píperasillíns natríums) 4 g Tazóbaktam (í formi tazóbaktam natríums) 0,50 g
English: 2 g piperacillin (in form of piperacillin sodium) and 0,25 g tazobactam (in form of tazobactam sodium).
Icelandic: 2 g píperasillín (í formi píperasillín natríums) og 0,25 g tazóbaktam (í formi tazóbaktam natríums).
English: to tazobactam 500 mg) 536,6 mg
Icelandic: 536,6 mg
English: Piperacillin (in the form of piperacillin sodium) 2 g Tazobactam (in the form of tazobactam sodium) 0.25 g
Icelandic: Píperasillín (í formi píperasillíns natríums) 2 g Tazóbaktam (í formi tazóbaktam natríums) 0,25 g
English: 2,085 g sodium piperacillin + 268,30 mg sodium tazobactam
Icelandic: 2,085 g natríum píperasillín + 268,30 mg natríum tazóbaktam
English: Piperacillin
Icelandic: Slóvenía
English: 4 g piperacillin (in form of piperacillin sodium) and 0,5 g tazobactam (in form of tazobactam sodium).
Icelandic: 4 g píperasillín (í formi píperasillín natríums) og 0,5 g tazóbaktam (í formi tazóbaktam natríums).
English: 2g piperacillin and 0.25g tazobactam (both present as sodium salts).
Icelandic: 2g píperasillín og 0,25g tazóbaktam (hvort tveggja til staðar sem natríumsölt).
English: 4,170 g sodium piperacillin + 536,60 mg sodium tazobactam
Icelandic: 4,170 g natríum píperasillín + 536,60 mg natríum tazóbaktam
English: 0.5366 g tazobactam sodium equivalent to 0.500 g tazobactam and 4.170 g piperacillin sodium equivalent to 4.00 g piperacillin
Icelandic: 0,5366 g tazóbaktam natríum sem jafngildir 0,500 g tazóbaktams og 4,170 g píperasillín natríum sem jafngildir 4,00 g píperasillíns
English: sodium 2.085 g
Icelandic: Píperasillín natríum 2,085 g
English: 1 injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.
Icelandic: 1 hettuglas með stungulyfi inniheldur píperasillín natríum sem jafngildir 4,0g af píperasillíni og tazóbaktam natríum sem jafngildir 0,5g af tazóbaktam.
English: 4g+0.500 g Powder for solution for infusion
Icelandic: 4g+0.500 g Innrennslisstofn í bláæð, lausn
English: 2.085 g of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam
Icelandic: 2,085 g af píperasillín natríum sem jafngildir 2 g af píperasillín og 0,2683 g af tazóbaktam natríum sem jafngildir 250 mg af tazóbaktam
English: 2.085 g sodium piperacillin equivalent to 2 g piperacillin and 0.2683 g sodium tazobactam equivalent to 0.250 g tazobactam.
Icelandic: 2,085 g natríum píperasillín sem jafngildir 2 g píperasillíns og 0,2683 g natríum tazóbaktam sem jafngildir 0,250 g tazóbaktams.
English: 4g piperacillin and 0.5g tazobactam (both present as sodium salts).
Icelandic: 4g píperasillín og 0,5g tazóbaktam (hvort tveggja til staðar sem natríumsölt).
English: 0.5 g tazobactam equivalent to 0.5366 g tazobactam sodium
Icelandic: 0,5366 g tazóbaktam natríum
English: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam.
Icelandic: Píperasillín natríum sem samsvarar píperasillíni 2 g, tazóbaktam natríum sem samsvarar tazóbaktam.
English: Pfizer, Coeur DéfenseTour A - La Défense 4 92931 PARIS LA DEFENSE Cedex
Icelandic: Pfizer, Coeur DéfenseTour A
English: Pfizer Corporation Austria Ges.m.b.H
Icelandic: Pfizer Corporation Austria Ges.
English: Piperacillin sodium corresponding to piperacillin 2 g and tazobactam sodium corresponding to tazobactam 0,25 g
Icelandic: Píperasillín natríum sem samsvarar píperasillíni 2 g og tazóbaktam natríum sem samsvarar tazóbaktam 0,25 g
English: Piperacillin.
Icelandic: Píperasillín
English: Tazonam 4,0 g/0,5 g
Icelandic: Tazonam 4,0 g/0,5 gTrockenstechampullen 4,0 g/0,5 g
English: 4.00 g as piperacillin sodium and tazobactam 0.5 g as tazobactam sodium.
Icelandic: Píperasillín 4,00 g sem píperasillín natríum og tazóbaktam 0,5 g sem tazóbaktam natríum
English: Tazocin® 2 g/ 250 mg 2g /250 mg Powder for solution for injection
Icelandic: Tazocin® 2 g/ 250 mg 2g /250 mg Stungulyfsstofn, lausn
English: 4.0g/0.5g
Icelandic: EF 4g/0,5g
English: Piperacillin 2g and tazobactam250mg both present as sodium salts.
Icelandic: Píperasillín 2g og tazóbaktam 250mg hvort tveggja til staðar sem natríumsölt.
English: Intravenous use 2 g piperacillinum / 0,25 g tazobactamum
Icelandic: Til notkunar í bláæð 2 g píperasillínum/ 0,25 g tazóbaktamum
English: to piperacillin 2g) 2085 mg Tazobactam sodium (equiv.
Icelandic: Píperasillín natríum (sem jafngildir píperasillín 2g) 2085 mg
English: Piperacillin sodium corresponding to piperacillin 4 g and tazobactam sodium corresponding to tazobactam 0,5 g
Icelandic: Píperasillín natríum sem samsvarar píperasillíni 4 g og tazóbaktam natríum sem samsvarar tazóbaktam 0,5 g
English: Tazocin4g/0.5g Powder for Solution for Injection or Infusion
Icelandic: Tazocin4g/0.5g Powder for Solution for Injection or
English: Lyophilisate for injection or infusion
Icelandic: Frostþurrkað stungulyf eða innrennslislyf, lausn
English: Piperacillin sodium corresponding to piperacillin 2 g, tazobactam sodium corresponding to tazobactam 0,25 g.
Icelandic: Píperasillín natríum sem samsvarar píperasillíni 2 g, tazóbaktam natríum sem samsvarar tazóbaktam 0,25 g.
English: Piperacillin sodium corresponding to piperacillin 4 g, tazobactam sodium corresponding to tazobactam 0,5 g
Icelandic: Píperasillín natríum sem samsvarar píperasillíni 4 g, tazóbaktam natríum sem samsvarar tazóbaktam 0,5 g
English: 4.17 g sodium piperacillin equivalent to 4 g piperacillin and 0.5366 g sodium tazobactam equivalent to 0.5 g tazobactam.
Icelandic: 4,17 g natríum píperasillín sem jafngildir 4 g píperasillíns og 0,5366 g natríum tazóbaktam sem jafngildir 0,5 g tazóbaktams.
English: to tazobactam 250 mg) 268,3 mg
Icelandic: Tazóbaktam natríum (sem jafngildir tazóbaktam 250 mg) 268,3 mg
English: Powder for solution for injection and infusion contains 2.085g piperacillin sodium equivalent to 2g piperacillin and 0.2683 g tazobactam sodium equivalent to 250 milligrams tazobactam
Icelandic: inniheldur 2,085g píperasillín natríum sem jafngildir 2g píperasillíns og 0,2683 g tazóbaktam natríum sem jafngildir 250 milligrömmum af tazóbaktam
English: Luxembourg
Icelandic: Helsinki Finland
English: to piperacillin 4 g) 4170 mg
Icelandic: Píperasillín natríum (sem jafngildir píperasillín 4 g) 4170 mg
English: 4000mg + 500 mg
Icelandic: + 500 mg
English: 4,170 g piperacillin sodium equivalent to 4000 mg of piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg of tazobactam.
Icelandic: 4,170 g píperasillín natríum sem jafngildir 4000 mg af píperasillíni og 0,5366 g tazóbaktam natríum sem jafngildir 500 mg af tazóbaktam
English: 4.170 g of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam
Icelandic: 4,170 g af píperasillíni natríum sem jafngildir 4 g af píperasillíni og 0,5366 g af tazóbaktam natríum sem jafngildir 500 mg af tazóbaktam
English: Intravenous use 4 g piperacillinum / 0,5 g tazobactamum
Icelandic: Til notkunar í bláæð 4 g píperasillínum/ 0,5 g tazóbaktamum
English: 4.170 g piperacillin sodium equivalent to 4 g piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg tazobactam.
Icelandic: 4,170 g píperasillín natríum sem jafngildir 4 g píperasillíns og 0,5366 g tazóbaktam natríum sem jafngildir 500 mg tazóbaktam.
English: 4.170 g piperacillin sodium equivalent to 4g piperacillin and 0.5366 g tazobactam sodium equivalent to 500 milligrams tazobactam
Icelandic: 4,170 g píperasillín natríum sem jafngildir 4g píperasillíns og 0,5366 g tazóbaktam natríum sem jafngildir 500 milligrömmum af tazóbaktam
English: 4.170 g piperacillin sodium equivalent to 4 g piperacillin and 0.5366 g tazobactam sodium equivalent to 500 milligrams tazobactam.
Icelandic: 4,170 g píperasillín natríum sem jafngildir 4 g píperasillíni og 0,5366 g tazóbaktam natríum sem jafngildir 500 milligrömmum af tazóbaktam.
English: 1 syringe
Icelandic: 1 sprautu
English: 20 vials
Icelandic: 20 hettuglasi
English: _ _ 1 Whole virion non-adjuvanted influenza vaccine, inactivated, containing antigen of *: A/Vietnam/1203/2004 (H5N1) 7.5 micrograms** per 0.5 ml dose * propagated in Vero cells (continuous cell line of mammalian origin) ** expressed in micrograms hemagglutinin
Icelandic: A/Víetnam/1203/2004 (H5N1) 7.5 míkrógrömm
English: Pack size multi-dose vial (glass)
Icelandic: Fjölskammta hettuglas (gler)
English: Single-dose prefilled syringe (glass) without needle
Icelandic: Áfyllta sprautu með stökum skammti (gler) án nál
English: Route of Administration
Icelandic: Pakkningastærð
English: Immediate Packaging Content (concentration)
Icelandic: Innihald (þéttni)
English: EU (MA) number Invented name
Icelandic: ESB markaðsleyfisnúmer
English: Route of administration
Icelandic: Dýrategund
English: EU/1/03/249/016 Vivanza 10 mg Orodispersible tablet blister (alu/alu) 4 x 1 tablets (unit dose)
Icelandic: 4 x 1 töflur (stakur skammtur)
English: Immediate Packaging
Icelandic: Til inntöku
English: Strength Pharmaceutical form Route of administration
Icelandic: ESB markaðsleyfisnúmer (Sér)heiti Styrkleiki Lyfjaform Íkomuleið Innri umbúðir Pakkningastærð
English: Package size
Icelandic: Ál/álþynna
English: (Invented) name Strength Pharmaceutical Form Route of Administration
Icelandic: Lyfjaform Íkomuleið Innri umbúðir
English: Packaging
Icelandic: Umbúðir
English: EU Number
Icelandic: Evrópskt markaðsleyfis -númer
English: 10 x 1 dose 50 x 1 dose
Icelandic: 10 x 1 skammtur 50 x 1 skammtur
English: Massachusetts 01702, USA
Icelandic: Massachusetts 01702, Bandaríkjunum.
English: ATCvet code: QI06AH07.
Icelandic: QI06AH07.
English: * Cell culture infectious dose 50%.
Icelandic: * Frumuræktaður smitandi skammtur 50%
English: : +30-210 6219520 info@virbac.gr
Icelandic: Τηλ. : +30-210 6219520 info@virbac.gr
English: Date of last renewal: 06/06/2014.
Icelandic: Nýjasta dagsetning endurnýjunar markaðsleyfis: 06/06/2014
English: VIRBAC SRL Via Ettore Bugatti, 15 20142 Milano Italia
Icelandic: VIRBAC SRL Via Ettore Bugatti, 15 20142
English: This resolves without any treatment.
Icelandic: Þetta gengur til baka án þess að meðferðar sé þörf.
English: NL: Nederland VIRBAC Nederland BV Hermesweg 15
Icelandic: Nederland VIRBAC Nederland BV Hermesweg 15
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Icelandic: Notið þetta dýralyf ekki eftir fyrningardagsetningu á umbúðunum á eftir EXP.
English: DE: Deutschland VIRBAC Tierarzneimittel GmbH Rögen 20
Icelandic: VIRBAC Tierarzneimittel GmbH Rögen 20
English: Store and transport refrigerated (2 C - 8 C).
Icelandic: Geymið og flytjið í kæli (2°C - 8°C).
English: AT: Österreich VIRBAC Österreich GmbH Hildebrandgasse 27
Icelandic: Österreich VIRBAC Österreich GmbH Hildebrandgasse 27
English: Puławska 314
Icelandic: z o.o. ul. Puławska 314
English: This local reaction could be a swelling, an oedema or a nodule and resolves spontaneously within from 3 to 4 weeks at the most.
Icelandic: Þessi einkenni á stungustað geta verið bjúgur, þroti eða hnökri og þau ganga sjálfkrafa til baka innan 3 til 4 vikna í mesta lagi.
English: Date of first authorisation: 25/06/2009.
Icelandic: Dagsetning fyrstu útgáfu markaðsleyfis: 25/06/2009.
English: IS: Ísland
Icelandic: Ísland
English: In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.
Icelandic: Í þeim tilvikum þegar gera má ráð fyrir móðurbornum mótefnum, kann að vera rétt að bólusetja þriðja sinni þegar 15 vikna aldri er náð.
English: No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.
Icelandic: Engar upplýsingar liggja fyrir um öryggi og verkun þessa bóluefnis við samtímis notkun neins annars dýralyfs.
English: It has been demonstrated that this spread did not cause adverse reactions on non-vaccinated cats.
Icelandic: Sýnt hefur verið fram á að þessi dreifing hafði ekki í för með sér aukaverkanir hjá köttum sem hafa ekki verið bólusettir.
English: De-worming at least 10 days prior to vaccination is recommended.
Icelandic: Mælt er með ormahreinsun að minnsta kosti 10 dögum fyrir bólusetningu.
English: HU : Magyarország VIRBAC Hungary KFT Szent Istvàn krt.11.II/21.
Icelandic: Magyarország VIRBAC Hungary KFT Szent Istvàn krt.11.II/21. 1055 Budapest Magyarország
English: Gelatin
Icelandic: Gelatína
English: PP MANUFACTURING CORPORATION 175 crossing Boulevard Suite 200, Framingham,
Icelandic: Boulevard, Suite 200, Framingham,
English: Primary vaccination: - first injection in kittens from 8 weeks of age - second injection 3 or 4 weeks later.
Icelandic: - Fyrsta inndæling eftir að kettlingar hafa náð 8 vikna aldri - Önnur inndæling 3 til 4 vikum síðar.
English: For active immunisation of cats from eight weeks of age against:
Icelandic: Virk mótefnamyndun hjá köttum sem eru 8 vikna eða eldri gegn:
English: For the leukaemia component, protection against persistent viraemia is observed in 73% of cats 3 weeks after their first vaccine injection.
Icelandic: Fyrir hvítblæðisþáttinn kemur vörn gegn þrálátri veirublóðsýkingu fram hjá 73% katta þremur vikum eftir fyrstu bólusetningu þeirra.
English: Detailed information on this product is available on the website of the European Medicines Agency (http://www.ema.europa.eu).
Icelandic: Ítarlegar upplýsingar um dýralyfið eru birtar á vef Lyfjastofnunar Evrópu (http://www.ema.europa.eu/).
English: Re-vaccinations:
Icelandic: Endurbólusetning (revaccination):
English: FI: Suomi/Finland VIRBAC
Icelandic: Suomi/Finland VIRBAC
English: Adjuvants: 3% aluminium hydroxide gel expressed as mg Al
Icelandic: 3% álhýdroxíðhlaup, tilgreint sem mg af Al
English: LU: Luxembourg/Luxemburg VIRBAC Belgium NV Esperantolaan 4
Icelandic: Luxembourg/Luxemburg VIRBAC Belgium NV Esperantolaan 4
English: Excipient: Stabilizing buffer containing gelatin: to
Icelandic: Stöðugleikaaukandi stuðpúði sem inniheldur gelatínu: að
English: DK: Danmark VIRBAC Danmark A/S Profilvej 1
Icelandic: Danmark VIRBAC Danmark A/S Profilvej 1
English: The vaccine contains the purified p45 FeLV-envelope antigen, obtained by genetic recombination of the E. coli strain.
Icelandic: Bóluefnið inniheldur hreinsaðan p45 FeLV-hjúps mótefnavaka sem fenginn er með erfðafræðilegri raðbrigðatækni úr E. coli stofni.
English: Cats
Icelandic: Kettir.
English: BE : België/Belgique VIRBAC Belgium NV Esperantolaan 4
Icelandic: België/Belgique VIRBAC Belgium NV Esperantolaan 4
English: Purified extract of Quillaja saponaria
Icelandic: Hreinsaður útdráttur úr Quillaja saponaria
English: Subcutaneous use (under the skin).
Icelandic: Til notkunar undir húð.
English: 06517 Carros France service-conso@virbac.fr
Icelandic: France VIRBAC France 13e rue LID 06517 Carros France service-conso@virbac.fr
English: After the primary vaccination course, the duration of immunity lasts for one year for all components.
Icelandic: Eftir grunnbólusetningarlotuna endist ónæmi í eitt ár fyrir alla þætti.
English: Excipient: Stabilizing buffer containing gelatin to 1.3 ml before freeze-drying
Icelandic: Stöðugleikaaukandi stuðpúði sem inniheldur gelatínu að 1,3 ml fyrir frostþurrkun
English: PL : Polska VIRBAC Sp. z o.o.
Icelandic: Polska VIRBAC Sp.
English: NO: Norge
Icelandic: Norge
English: Maternally derived antibodies, especially those against feline panleucopenia virus, can negatively influence the immune response to vaccination.
Icelandic: Móðurborin mótefni, sérstaklega þau sem eru gegn kattafársvírus, geta haft neikvæð áhrif á ónæmissvörun við bólusetningunni.
English: The transient signs following vaccination such as hyperthermia (lasting 1 to 4 days), apathy and digestive disturbances may also be commonly observed.
Icelandic: Skammvinn einkenni eftir bólusetningu eins og hækkaðan líkamshita (varir í 1 til 4 daga), sinnuleysi og meltingartruflanir er einnig algengt að sjá.
English: After the second injection, and subsequent administrations, this reaction is markedly reduced.
Icelandic: Þegar lyfið er gefið með inndælingu öðru sinni og þaðan í frá eru þessi einkenni mun vægari.
English: LV: Latvija
Icelandic: Latvija
English: 102 µg
Icelandic: 102 μg
English: A moderate and transient local reaction (<2 cm) is commonly observed after the first injection.
Icelandic: Algengt er að í meðallagi alvarleg og tímabundin einkenni (≤ 2 cm) komi fyrir á stungustað eftir fyrstu inndælingu.
English: In this case, since annual revaccination is required for calicivirus, rhinotracheitis virus and panleucopenia virus components, a single dose of FELIGEN RCP can be used annually.
Icelandic: Í þessu tilviki má, vegna þess að endurbólusetja þarf árlega fyrir veiruþáttum kattakvefs, kattaflensu og kattafárs, gefa stakan skammt af FELIGEN RCP árlega
English: EE : Eesti
Icelandic: Eesti
English: Febrile limping syndrome reactions may occur very rarely in kittens, as reported in the literature after the use of any vaccine containing a Feline Calicivirus component.
Icelandic: Örsjaldan geta viðbrögð heilkennis helti með hita (febrile limping syndrome) komið fyrir hjá kettlingum, eins og greint hefur verið frá í birtum gögnum eftir notkun allra bóluefna sem innihalda kattakvefsveiruþátt (Feline Calicivirus).
English: Suspension for LEUCOFELIGEN FeLV/RCP, for cats
Icelandic: Leysir fyrir LEUCOFELIGEN FeLV/RCP, fyrir ketti
English: The vaccine can be used as a booster for kittens or cats previously vaccinated with FELIGEN RCP and LEUCOGEN separately.
Icelandic: Nota má bóluefni til örvunar ónæmis hjá kettlingum og köttum sem hafa áður verið bólusettir með FELIGEN RCP og LEUCOGEN sitt í hvoru lagi.
English: Box of 10 or 50 lyophilisate vials and 10 or 50 suspension vials
Icelandic: Askja sem í eru 10 eða 50 hettuglös með frostþurrkuðu þurrefni og 10 eða 50 hettuglös með dreifu
English: Special precautions for use in animals:
Icelandic: Sérstakar varúðarreglur við notkun hjá dýrum :
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Icelandic: - Mjög algengar (aukaverkanir koma fyrir hjá fleiri en 1 af hverjum 10 dýrum sem fá meðferð) - Algengar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 100 dýrum sem fá meðferð) - Sjaldgæfar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 1.000 dýrum sem fá meðferð) - Mjög sjaldgæfar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 10.000 dýrum sem fá meðferð)
English: RO: România VIRBAC
Icelandic: România VIRBAC
English: Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia.
Icelandic: Bóluefni gegn kattaflensuveiru (feline viral rhinotracheitis), kattakvefi (feline calicivirosis), kattafári (feline panleucopenia) og kattahvítblæði.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Icelandic: LÁGMARKS UPPLÝSINGAR SEM SKULU KOMA FRAM Á LITLUM
English: Do not use in pregnant cats.
Icelandic: Ekki má nota lyfið handa kettlingafullum læðum.
English: Sodium chloride Disodium phosphate anhydrous Potassium dihydrogen phosphate Aluminium hydroxide gel Quillaja saponaria Water for injections
Icelandic: Natríumklóríð Dinatríumfosfat, vatnsfrítt Kalíumdihýdrogenfosfat Álhýdroxíðgel Quillaja saponaria
English: Sodium chloride
Icelandic: Kalíumhýdroxíð.
English: No adverse reactions were observed after an overdose administration (10 doses of lyophilisate and 2 doses of suspension) of the veterinary medicinal product other than those mentioned in section 4.6 except local reactions that can last longer (from 5 to 6 weeks at the most).
Icelandic: Ekki hefur orðið vart við neinar aukaverkanir eftir ofskömmtun (10 skammtar af frostþurrkuðu þurrefni og 2 skammtar af dreifu) með dýralyfinu, aðrar en þær sem nefndar eru í kafla 4.6, nema hvað varðar langvinnari staðbundin áhrif á stungustað (vara í 5 til 6 vikur í mesta lagi).
English: EXP {month/year} Once reconstituted use immediately.
Icelandic: EXP {mánuður/ár} Notið lyfið strax eftir blöndun.
English: CY: Κύπρος
Icelandic: Κύπρος
English: The onset of immunity has been demonstrated from: - 3 weeks after the primary vaccination for the panleucopenia and leukaemia components - 4 weeks after the primary vaccination for the calicivirus and rhinotracheitis virus components.
Icelandic: - 3 vikum eftir grunnbólusetningu (primary vaccination) hvað varðar kattafárs- og hvítblæðisþættina - 4 vikum eftir grunnbólusetningu hvað varðar kattakvefs- og kattaflensuþættina.
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Icelandic: Ef sá sem annast lyfjagjöf sprautar sig með dýralyfinu fyrir slysni, skal tafarlaust leita til læknis og hafa meðferðis fylgiseðil eða umbúðir dýralyfsins.
English: Lyophilisate:
Icelandic: Dreifa:
English: Therefore, a test for presence of FeLV before vaccination is recommended.
Icelandic: Því er mælt með að fyrir bólusetningu sé rannsakað hvort FeLV er til staðar.
English: BG: Република България VIRBAC
Icelandic: Република България VIRBAC
English: Shelf life after reconstitution according to directions: use immediately.
Icelandic: Geymsluþol eftir þynningu eða blöndun samkvæmt leiðbeiningum:
English: Per dose of 1 ml:
Icelandic: Hver 1 ml skammtur inniheldur:
English: No adverse reactions were observed after an overdose administration (10 doses of lyophilisate and 2 doses of suspension) of the veterinary medicinal product other than those mentioned in section 6 except local reactions that can last longer (from 5 to 6 weeks at the most).
Icelandic: Ekki hefur orðið vart við neinar aukaverkanir eftir ofskömmtun (10 skammtar af frostþurrkuðu þurrefni og 2 skammtar af dreifu) með dýralyfinu, aðrar en þær sem nefndar eru í kafla 6, nema hvað varðar langvinnari staðbundin áhrif á stungustað (vara í 5 til 6 vikur í mesta lagi).
English: Marketing authorisation holder and manufacturer responsible for the batch release:
Icelandic: Markaðsleyfishafi og framleiðandi sem ber ábyrgð á lokasamþykkt:
English: Live attenuated feline viral rhinotracheitis virus (strain F2)
Icelandic: Lifandi veikluð kattaflensuveira (feline viral rhinotracheitis virus) (F2 stofn)
English: Live attenuated feline calicivirus (strain F9)
Icelandic: Lifandi veikluð kattakvefsveira (feline calicivirus) (F9 stofn)